Pediatric Primary Care Case Studies (143 page)

family-centered care,
4

evidenced based care and,
1
–2

fundamental contexts of,
1
–2,
6

problem domains and,
2
–3

processes for,
5

resources for,
7

diaries, blood glucose,
268
t

diarrhea/vomiting,
387
–404

case presentation for,
387
–388,
394
–395,
400

diagnosis of,
392
–397

death risk factors,
391
–392

diagnostic testing,
396
–397

differential,
393
t,
395
–396

history-taking,
391
–395

hospitalization risk factors,
391
–392

telephone consultations,
391
–395

epidemiology/etiology of,
388
–395

acute
vs
. chronic diarrhea,
391
–392

causative agents,
388
–389

CNDC,
391
–392

pathophysiology,
389
–390

fundamental contexts of,
387
,
400
–401

gastroenteritis,
397
–401

management of,
397
–400

feeding resumption,
397
–399

follow-up visits,
399
–400

hydration/rehydration,
397
,
398
t

medications,
399

objectives for,
387

resources for,
401
–402

Differin.
See
adapalene (Differin)

diphenhydramine,
68

discussion of cases.
See
case studies (pediatric primary care)

diseases

acne (adolescents),
467
–480

anemia (toddlers),
291
–320

birth control (adolescents),
427
–440

cough,
377
–386

diagnostic reasoning for,
1
–8

fever,
233
–250

headache,
321
–335

high blood sugar/overweight,
267
–290

itchy rash,
455
–466

limp,
481
–492

oral trauma,
405
–416

recurrent ear infections (toddlers),
347
–358

red eye (preschoolers),
335
–346

short stature,
507
–518

syncope,
359
–376

urinary urgency/incontinence (preschoolers),
417
–426

vaginal discharge (adolescents),
441
–454

vomiting/diarrhea,
387
–404

well-child care (late-preterm infants),
493
–506

wheezing,
251
–266

DKA (diabetic ketoacidosis),
267
–268,
267
–269,
275
t

domains, problem,
2
–3

Dove soap,
460

doxycycline,
383
–384,
472
–473,
475
t–477t

drawings as abuse indicators,
201

drug therapies.
See
medications

DSM-IV-TR (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revisions)

AD diagnostic criteria,
30
f

ADHD criteria

criteria,
176
–178,
177
t–178t

duloxetine (Cymbalta),
218

dysenteric diarrhea,
390

dysfunctional elimination syndrome.
See
DES (dysfunctional elimination syndrome)

dyshidrotic eczema,
459

E

ear infections (toddlers),
347
–358

case presentation for,
347
–348,
351
,
354
–355

diagnosis of,
350
–356

AOM,
347
–356

diagnostic testing,
352

history-taking,
348
–351

OME,
347
–356

physical examination,
351

epidemiology/etiology of,
348
–350

pathophysiology,
350
–351

risk factors,
349
–350

fundamental contexts of,
347
–348,
357

management of,
352
–356

AAP recommendations,
353
–356

education plans,
354

follow-up visits,
354
–355

medications,
352
–356,
353
t,
355
t

SNAP,
353

therapeutic plans,
352
–353

objectives for,
347

resources for,
357
–358

EBV (Epstein-Barr virus),
235
–237

educational objectives.
See
objectives

Effexor.
See
venlafaxine (Effexor)

Elestat.
See
epinastine HCl (Elestat)

Elidel.
See
pimecrolimus (Elidel)

Emadine.
See
emedastine difumarate (Emadine)

emedastine difumarate (Emadine),
343
t

Emergency contraception,
434

encopresis (school-age children),
115
–132

diagnosis of,
117
–122

diagnostic testing,
120
–121

history-taking,
118
–119

physical examinations,
120
–122

Rome III criteria for,
117
t

epidemiology/etiology of,
116
–117,
117
–118

fundamental contexts of,
115
–116,
130
–131

management of,
124
t–125t,
126
–130,
129
t

follow-up visits,
126
,
130

medications,
124
t–125t,
129
t

parental education,
127
–128

objectives for,
115

prognosis for,
130

resources for,
131
–132

Entamoeba histolytica
,
388

environmental toxins,
296
–299,
298
t–299t

Epiceram,
460

epidemiology/etiology

of developmental problems

fatigue (adolescents),
60
–61